COVID - 19 Vaccination Update - Day 612 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 19 SEP 2022 8:22PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 216.81 Crore (2,16,81,32,006) today. More than 10 lakh (10,42,670) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10414880
	2^nd Dose	10114224
	Precaution Dose	6947581
FLWs	1^st Dose	18436181
	2^nd Dose	17711388
	Precaution Dose	13515963
Age Group 12-14 years	1^st Dose	40829544
	2^nd Dose	31280687
Age Group 15-18 years	1^st Dose	61878315
	2^nd Dose	52861101
Age Group 18-44 years	1^st Dose	561097034
	2^nd Dose	515095528
	Precaution Dose	85960047
Age Group 45-59 years	1^st Dose	203999043
	2^nd Dose	196807725
	Precaution Dose	44933064
Over 60 years	1^st Dose	127647264
	2^nd Dose	123038615
	Precaution Dose	45563822
Cumulative 1^st dose administered		1024302261
Cumulative 2^nd dose administered		946909268
Precaution Dose		196920477
Total		2168132006

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 19^th September, 2022 (612^th Day)
HCWs	1^st Dose	14
	2^nd Dose	141
	Precaution Dose	5503
FLWs	1^st Dose	36
	2^nd Dose	280
	Precaution Dose	9752
Age Group 12-14 years	1^st Dose	14401
	2^nd Dose	26988
Age Group 15-18 years	1^st Dose	6202
	2^nd Dose	13530
Age Group 18-44 years	1^st Dose	11112
	2^nd Dose	40444
	Precaution Dose	549918
Age Group 45-59 years	1^st Dose	1658
	2^nd Dose	8939
	Precaution Dose	239097
Over 60 years	1^st Dose	1054
	2^nd Dose	5926
	Precaution Dose	107675
Cumulative 1^st dose administered		34477
Cumulative 2^nd dose administered		96248
Precaution Dose		911945
Total		1042670

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.